Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;201(7):3193-3201.
doi: 10.1007/s12011-022-03424-y. Epub 2022 Sep 27.

Bloodlettings in Hemochromatosis Result in Increased Blood Lead (Pb) Concentrations

Affiliations

Bloodlettings in Hemochromatosis Result in Increased Blood Lead (Pb) Concentrations

Mazyar Yazdani et al. Biol Trace Elem Res. 2023 Jul.

Abstract

Hemochromatosis is a hereditary disorder, most often associated with mutations of the HFE (High FErrum) gene. If left untreated, it can result in severe parenchymal iron accumulation. Bloodletting is the mainstay treatment. We have previously shown that treatment of hemochromatosis by repeated bloodlettings may induce changes in the serum levels of several trace elements. The aim of this work was to evaluate if whole blood concentrations of the environmental pollutants lead (Pb), mercury (Hg), and cadmium (Cd) could be affected by bloodlettings. We recruited 28 patients and 21 healthy individuals (control group). Whole blood and urine levels of Pb, Hg, and Cd were measured before the start and after the completion of treatment using inductively coupled plasma mass spectrometry, together with serum iron and liver function tests. Concentrations of blood Pb, but not Hg or Cd, were significantly increased after treatment. The increase in Pb was higher in C282Y homozygous patients than in the other patients, and it was positively correlated with the serum concentration of alkaline phosphatase. Bloodlettings in hemochromatosis result in an increase in the blood concentration of Pb. Augmented absorption due to iron loss or Pb mobilization from bone may contribute to the higher blood Pb level.

Keywords: Bloodletting; Cadmium; Hemochromatosis; Lead; Mercury; Trace elements.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Age and sex distribution of subjects
Fig. 2
Fig. 2
Distribution of genotypes by gender
Fig. 3
Fig. 3
The relationship of Pb levels with pre-treatment ALP levels in blood

Similar articles

Cited by

References

    1. Kowdley KV, Brown KE, Ahn J, Sundaram V (2019) ACG clinical guideline: hereditary hemochromatosis. Off J Am Coll Gastroenterol 114:1202–1218 - PubMed
    1. Åsberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelønning K, Fjøsne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol. 2001;36:1108–1115. doi: 10.1080/003655201750422747. - DOI - PubMed
    1. Kane SF, Roberts C, Paulus R. Hereditary hemochromatosis: rapid evidence review. Am Fam Physician. 2021;104:263–270. - PubMed
    1. Sandnes M, Vorland M, Ulvik RJ, Reikvam H. HFE genotype, ferritin levels and transferrin saturation in patients with suspected hereditary hemochromatosis. Genes. 2021;12:1162. doi: 10.3390/genes12081162. - DOI - PMC - PubMed
    1. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Ann Intern Med. 1998;129:932–939. doi: 10.7326/0003-4819-129-11_Part_2-199812011-00003. - DOI - PubMed